SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is trending amid market volatility driven by concerns over rising Treasury yields, higher oil prices, and uncertainty surrounding the pace of artificial intelligence development. Traders are closely monitoring the upcoming Federal Reserve policy meeting, with most expecting a rate hike.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

Investors are actively debating the Federal Reserve's next policy move as rising Treasury yields and persistent inflation keep upward pressure on interest rates. The community is focused on the impact of these macro headwinds, with many traders expressing bearish sentiment toward bond prices as market expectations for a rate hike grow.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing volatility as traders debate the impact of broader market uncertainty and mixed signals regarding AI development, with many investors maintaining bullish long-term sentiment based on the company's foundry prospects. While some react to speculative rumors about potential partnerships, others are focusing on the stock's technical price action and technical support levels.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, and Defense. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce is trending as investors anticipate upcoming half-year earnings and updates on potential major hyperscaler data center contracts. The conversation is driven by the company's strong performance across its Civil Aerospace, Defence, and Power Systems divisions, alongside ongoing community enthusiasm for its small modular reactor (SMR) development.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is trending as traders react to the early completion of enrollment for the Phase 3 APPROACH trial of HLP003, while also digesting the impact of a recent equity offering. Community sentiment remains focused on the company's potential as an acquisition target and its upcoming late-stage clinical readouts compared to sector peers.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment shares are receiving significant attention following the announcement of a multi-million dollar contract for its directed-energy counter-drone laser systems. Traders are debating whether this development and the company's strong, record-breaking backlog will catalyze a price recovery, with many expressing frustration over the stock's recent downward performance despite positive fundamental news.

Nasdaq, Inc. is a holding company, which engages in trading, clearing, exchange technology, regulatory, securities listing, information, and public and private company services. It operates through the following segments: Capital Access Platforms, Financial Technology, and Market Services. The Capital Access Platforms segment delivers liquidity, transparency, and integrity to the corporate issuer and investment community by empowering clients to effectively navigate the capital markets, achieve their sustainability goals, and drive governance excellence. The Financial Technology segment offers platforms that improve the liquidity, transparency, and integrity of the global economy by architecting and operating the markets. The Market Services segment includes equity derivative trading and clearing, cash equity trading, fixed income, currency, and commodities trading. The company was founded by Gordon S. Macklin in 1971 and is headquartered in New York, NY.

Nasdaq Inc - Ordinary Shares - 144A

Nasdaq Inc

The community is focused on Nasdaq's strategic initiative to implement 23-hour trading, which has sparked debate regarding increased liquidity versus potential overnight volatility. Traders are also monitoring the impact of regulatory updates and ongoing index inclusion activity on the exchange's market structure.

Zoracles

Zoracles is experiencing increased community attention and volatility as traders debate the potential for a short squeeze driven by high future contract positions relative to its market cap. While some investors remain bullish on long-term growth and utility, others express frustration over extended price stagnation and characterize the project as a speculative pump and dump.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased activity following the official completion of its acquisition of Chain Technology and Services, which integrates real-world payment infrastructure directly into the Onyx ecosystem. While some traders view this as a foundational step toward institutional adoption and a neobank launch, others express skepticism, characterizing the price action as speculative volatility or a potential pump-and-dump scheme.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is receiving attention as traders anticipate the release of Phase 2 maintenance data for its obesity drug VK2735, with the community split between bullish expectations for the trial results and frustration over the stock's recent price performance and management's communication. Investors are closely watching for any signs of a partnership or acquisition, though debate continues regarding the potential for clinical success versus the risk of dilution or further market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CRDF Is an $SLS type move or acquisition by $PFE to much to ask?

Zschopower

Charles ford

StockTwits Web

Cardiff Oncology Inc

SELLAS Life Sciences Group Inc

Pfizer Inc

James

@jrh34 I might buy it and take it private